MedTrace Logo

Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

NCT03385031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2019-03-08

No results posted yet for this study

Summary

In a retrospective study the investigators defined quantitative action levels based on dose and volume measures for adaptive radiation therapy in breast cancer patients (Zegers et al. Acta Oncol 2017). The aim of this study is to validate these parameters in a prospective study.

Conditions

Interventions

OTHER

CBCT imaging

CBCT imaging at first and last fraction of radiotherapy treatment

Sponsors & Collaborators

  • Maastricht Radiation Oncology

    lead OTHER

Principal Investigators

  • Karolien Verhoeven, PHD · Radiation Oncologist

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-08-20
Completion
2018-08-20

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03385031 on ClinicalTrials.gov